Cargando…
Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease (ILD) characterized by the proliferation of fibroblasts and aberrant accumulation of extracellular matrix. These changes are accompanied by structural destruction of the lung tissue and the progressive decline of pulmonary fu...
Autores principales: | Kou, Leiya, Kou, Pei, Luo, Guangwei, Wei, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957418/ https://www.ncbi.nlm.nih.gov/pubmed/35345828 http://dx.doi.org/10.1155/2022/6197219 |
Ejemplares similares
-
Current Progress and Perspectives on Using Gold Compounds for the Modulation of Tumor Cell Metabolism
por: Kou, Leiya, et al.
Publicado: (2021) -
The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014) -
Cell Therapy in Idiopathic Pulmonary Fibrosis†
por: Serrano-Mollar, Anna
Publicado: (2018) -
Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment
por: Cilli, Aykut, et al.
Publicado: (2023) -
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2017)